354 related articles for article (PubMed ID: 31013259)
1. Activation of the calcium sensing receptor attenuates TRPV6-dependent intestinal calcium absorption.
Lee JJ; Liu X; O'Neill D; Beggs MR; Weissgerber P; Flockerzi V; Chen XZ; Dimke H; Alexander RT
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31013259
[TBL] [Abstract][Full Text] [Related]
2. Juxtaglomerular cell CaSR stimulation decreases renin release via activation of the PLC/IP(3) pathway and the ryanodine receptor.
Ortiz-Capisano MC; Reddy M; Mendez M; Garvin JL; Beierwaltes WH
Am J Physiol Renal Physiol; 2013 Feb; 304(3):F248-56. PubMed ID: 23220722
[TBL] [Abstract][Full Text] [Related]
3. Calcium-sensing receptor regulates intestinal dipeptide absorption via Ca
Xu J; Zeug A; Riederer B; Yeruva S; Griesbeck O; Daniel H; Tuo B; Ponimaskin E; Dong H; Seidler U
Physiol Rep; 2020 Jan; 8(1):e14337. PubMed ID: 31960592
[TBL] [Abstract][Full Text] [Related]
4. Functional TRPV6 channels are crucial for transepithelial Ca2+ absorption.
Woudenberg-Vrenken TE; Lameris AL; Weißgerber P; Olausson J; Flockerzi V; Bindels RJ; Freichel M; Hoenderop JG
Am J Physiol Gastrointest Liver Physiol; 2012 Oct; 303(7):G879-85. PubMed ID: 22878123
[TBL] [Abstract][Full Text] [Related]
5. Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders.
Nemeth EF; Shoback D
Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):373-84. PubMed ID: 23856266
[TBL] [Abstract][Full Text] [Related]
6. Villin promoter-mediated transgenic expression of transient receptor potential cation channel, subfamily V, member 6 (TRPV6) increases intestinal calcium absorption in wild-type and vitamin D receptor knockout mice.
Cui M; Li Q; Johnson R; Fleet JC
J Bone Miner Res; 2012 Oct; 27(10):2097-107. PubMed ID: 22589201
[TBL] [Abstract][Full Text] [Related]
7. Recent updates on the calcium-sensing receptor as a drug target.
Trivedi R; Mithal A; Chattopadhyay N
Curr Med Chem; 2008; 15(2):178-86. PubMed ID: 18220773
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Clinical Aspects of the Target Therapy with the Calcimimetic Cinacalcet in the Treatment of Parathyroid Tumors.
Mingione A; Verdelli C; Terranegra A; Soldati L; Corbetta S
Curr Cancer Drug Targets; 2015; 15(7):563-74. PubMed ID: 26033088
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase C-mediated regulation of transient receptor potential vanilloid 6 channels: implications in active intestinal Ca2+ transport.
Thyagarajan B; Benn BS; Christakos S; Rohacs T
Mol Pharmacol; 2009 Mar; 75(3):608-16. PubMed ID: 19073818
[TBL] [Abstract][Full Text] [Related]
10. TRPV6 and Ca
Beggs MR; Lee JJ; Busch K; Raza A; Dimke H; Weissgerber P; Engel J; Flockerzi V; Alexander RT
Cell Mol Gastroenterol Hepatol; 2019; 8(4):625-642. PubMed ID: 31398491
[TBL] [Abstract][Full Text] [Related]
11. Calcium-sensing receptor activation in chronic kidney disease: effects beyond parathyroid hormone control.
Massy ZA; Hénaut L; Larsson TE; Vervloet MG
Semin Nephrol; 2014 Nov; 34(6):648-59. PubMed ID: 25498383
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a calcimimetic with differential effects on parathyroid hormone and calcitonin secretion.
Henley C; Yang Y; Davis J; Lu JY; Morony S; Fan W; Florio M; Sun B; Shatzen E; Pretorius JK; Richards WG; St Jean DJ; Fotsch C; Reagan JD
J Pharmacol Exp Ther; 2011 Jun; 337(3):681-91. PubMed ID: 21422163
[TBL] [Abstract][Full Text] [Related]
13. Calcium-Sensing Receptor Genotype and Response to Cinacalcet in Patients Undergoing Hemodialysis.
Moe SM; Wetherill L; Decker BS; Lai D; Abdalla S; Long J; Vatta M; Foroud TM; Chertow GM
Clin J Am Soc Nephrol; 2017 Jul; 12(7):1128-1138. PubMed ID: 28630081
[TBL] [Abstract][Full Text] [Related]
14. Activation of calcium-sensing receptor by allosteric agonists cinacalcet and AC-265347 abolishes the 1,25(OH)
Wongdee K; Rodrat M; Keadsai C; Jantarajit W; Teerapornpuntakit J; Thongbunchoo J; Charoenphandhu N
Arch Biochem Biophys; 2018 Nov; 657():15-22. PubMed ID: 30217510
[TBL] [Abstract][Full Text] [Related]
15. Coordinated control of renal Ca(2+) transport proteins by parathyroid hormone.
van Abel M; Hoenderop JG; van der Kemp AW; Friedlaender MM; van Leeuwen JP; Bindels RJ
Kidney Int; 2005 Oct; 68(4):1708-21. PubMed ID: 16164647
[TBL] [Abstract][Full Text] [Related]
16. Trpv6 mediates intestinal calcium absorption during calcium restriction and contributes to bone homeostasis.
Lieben L; Benn BS; Ajibade D; Stockmans I; Moermans K; Hediger MA; Peng JB; Christakos S; Bouillon R; Carmeliet G
Bone; 2010 Aug; 47(2):301-8. PubMed ID: 20399919
[TBL] [Abstract][Full Text] [Related]
17. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
Torres PU
J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of Ca2+-sensing receptor inhibits the basolateral 50-pS K channels in the thick ascending limb of rat kidney.
Kong S; Zhang C; Li W; Wang L; Luan H; Wang WH; Gu R
Biochim Biophys Acta; 2012 Feb; 1823(2):273-81. PubMed ID: 22050992
[TBL] [Abstract][Full Text] [Related]
19. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney disease.
Quarles LD
Kidney Int Suppl; 2005 Jul; (96):S24-8. PubMed ID: 15954947
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase C inhibitor, U73122, releases intracellular Ca2+, potentiates Ins(1,4,5)P3-mediated Ca2+ release and directly activates ion channels in mouse pancreatic acinar cells.
Mogami H; Lloyd Mills C; Gallacher DV
Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):645-51. PubMed ID: 9182729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
